Bulk Inquiry
ZG-2686
- Soluble in DMSO
- MF: C13H9BrN4O
- MW: 317.14
Description
ZG-2686 is a potent HIF-2α agonist with an EC50 value of 0.25 μM. In cellular assays, ZG-2686 synergistically enhanced HIF-2α-dependent EPO gene expression when combined with the clinically approved prolyl hydroxylase domain (PHD) inhibitor Vadadustat (Axon 3288). As an optimized version, ZG-2686 exhibited significantly improved HIF-2α activity (Emax = 375%) compared to ZG-2033 (Axon 3596).
More Information
| Parent CAS No. | 1795110-22-3 |
|---|---|
| Chemical Name | N-(1,2,7-Triaza-1H-inden-3-yl)4-bromobenzamide |
| Short Description | HIF-2α agonist |
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 2034 | HIF-2 inhibitor 2 |
From $104.50 |
| 2480 | LW6 |
From $93.50 |
| 2614 | HIF-2a Translation Inhibitor 76 |
From $77.00 |
| 2959 | FM19G11 |
From $104.50 |
| 3596 | ZG-2033 |
From $143.00 |
| 3760 | Belzutifan |
From $308.00 |


